nodes	percent_of_prediction	percent_of_DWPC	metapath
Azacitidine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—head and neck cancer	0.888	1	CiPCiCtD
Azacitidine—CDA—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.00406	0.114	CbGpPWpGaD
Azacitidine—CDA—Pyrimidine metabolism—DPYD—head and neck cancer	0.00348	0.0978	CbGpPWpGaD
Azacitidine—CDA—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.0027	0.0758	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—ING3—head and neck cancer	0.00226	0.0635	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—CEBPA—head and neck cancer	0.00225	0.0632	CbGpPWpGaD
Azacitidine—CDA—Pyrimidine metabolism—TYMS—head and neck cancer	0.00198	0.0557	CbGpPWpGaD
Azacitidine—CDA—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.00192	0.0539	CbGpPWpGaD
Azacitidine—DNMT3A—One Carbon Metabolism—TYMS—head and neck cancer	0.00183	0.0514	CbGpPWpGaD
Azacitidine—DNMT3A—Trans-sulfuration and one carbon metabolism—TYMS—head and neck cancer	0.00164	0.0462	CbGpPWpGaD
Azacitidine—CDA—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.00154	0.0432	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CEBPA—head and neck cancer	0.00146	0.0411	CbGpPWpGaD
Azacitidine—CDA—Nucleotide metabolism—DPYD—head and neck cancer	0.00136	0.0381	CbGpPWpGaD
Azacitidine—DNMT3A—connective tissue—head and neck cancer	0.00125	0.104	CbGeAlD
Azacitidine—DNMT1—One Carbon Metabolism—TYMS—head and neck cancer	0.00124	0.0347	CbGpPWpGaD
Azacitidine—DNMT1—Trans-sulfuration and one carbon metabolism—TYMS—head and neck cancer	0.00111	0.0312	CbGpPWpGaD
Azacitidine—DNMT3A—lymphoid tissue—head and neck cancer	0.00091	0.0763	CbGeAlD
Azacitidine—CDA—lymphoid tissue—head and neck cancer	0.00086	0.0721	CbGeAlD
Azacitidine—DNMT1—parotid gland—head and neck cancer	0.000856	0.0717	CbGeAlD
Azacitidine—DNMT3A—thyroid gland—head and neck cancer	0.000827	0.0693	CbGeAlD
Azacitidine—DNMT1—saliva-secreting gland—head and neck cancer	0.00082	0.0687	CbGeAlD
Azacitidine—CDA—thyroid gland—head and neck cancer	0.000782	0.0655	CbGeAlD
Azacitidine—CDA—Nucleotide metabolism—TYMS—head and neck cancer	0.000773	0.0217	CbGpPWpGaD
Azacitidine—DNMT1—connective tissue—head and neck cancer	0.000753	0.0631	CbGeAlD
Azacitidine—DNMT3A—head—head and neck cancer	0.000734	0.0615	CbGeAlD
Azacitidine—CDA—Nucleotide metabolism—GPX1—head and neck cancer	0.000732	0.0205	CbGpPWpGaD
Azacitidine—DNMT1—epithelium—head and neck cancer	0.000715	0.0599	CbGeAlD
Azacitidine—Gemcitabine—TYMS—head and neck cancer	0.000713	0.563	CrCbGaD
Azacitidine—DNMT1—trachea—head and neck cancer	0.000632	0.053	CbGeAlD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—BCL2—head and neck cancer	0.000561	0.0158	CbGpPWpGaD
Azacitidine—Adenosine triphosphate—AKT1—head and neck cancer	0.000553	0.437	CrCbGaD
Azacitidine—DNMT1—lymphoid tissue—head and neck cancer	0.000551	0.0461	CbGeAlD
Azacitidine—Cellulitis—Vinblastine—head and neck cancer	0.00055	0.00877	CcSEcCtD
Azacitidine—Febrile neutropenia—Fluorouracil—head and neck cancer	0.000546	0.00871	CcSEcCtD
Azacitidine—Bone pain—Vinblastine—head and neck cancer	0.000522	0.00833	CcSEcCtD
Azacitidine—DNMT3A—lymph node—head and neck cancer	0.000514	0.043	CbGeAlD
Azacitidine—Prurigo—Docetaxel—head and neck cancer	0.000513	0.00819	CcSEcCtD
Azacitidine—CDA—Fluoropyrimidine Activity—TP53—head and neck cancer	0.00051	0.0143	CbGpPWpGaD
Azacitidine—DNMT1—thyroid gland—head and neck cancer	0.0005	0.0419	CbGeAlD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—TYMS—head and neck cancer	0.000499	0.014	CbGpPWpGaD
Azacitidine—CDA—lymph node—head and neck cancer	0.000485	0.0407	CbGeAlD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—CCND1—head and neck cancer	0.000481	0.0135	CbGpPWpGaD
Azacitidine—Neoplasm—Vinblastine—head and neck cancer	0.000452	0.00721	CcSEcCtD
Azacitidine—DNMT1—head—head and neck cancer	0.000444	0.0372	CbGeAlD
Azacitidine—DNMT3A—RMTs methylate histone arginines—CCND1—head and neck cancer	0.000419	0.0118	CbGpPWpGaD
Azacitidine—Neoplasm—Hydroxyurea—head and neck cancer	0.000413	0.00658	CcSEcCtD
Azacitidine—Haemorrhoids—Docetaxel—head and neck cancer	0.000403	0.00643	CcSEcCtD
Azacitidine—Febrile neutropenia—Docetaxel—head and neck cancer	0.000394	0.00628	CcSEcCtD
Azacitidine—Polyp—Docetaxel—head and neck cancer	0.00039	0.00621	CcSEcCtD
Azacitidine—Hepatic failure—Hydroxyurea—head and neck cancer	0.000369	0.00588	CcSEcCtD
Azacitidine—Cellulitis—Fluorouracil—head and neck cancer	0.000361	0.00576	CcSEcCtD
Azacitidine—Herpes simplex—Fluorouracil—head and neck cancer	0.000356	0.00568	CcSEcCtD
Azacitidine—Cyst—Docetaxel—head and neck cancer	0.000355	0.00565	CcSEcCtD
Azacitidine—Pharyngolaryngeal pain—Docetaxel—head and neck cancer	0.000351	0.0056	CcSEcCtD
Azacitidine—Laryngeal pain—Docetaxel—head and neck cancer	0.000348	0.00555	CcSEcCtD
Azacitidine—Inflammation—Fluorouracil—head and neck cancer	0.000339	0.0054	CcSEcCtD
Azacitidine—CDA—Metabolism—UROD—head and neck cancer	0.000338	0.0095	CbGpPWpGaD
Azacitidine—Interstitial lung disease—Docetaxel—head and neck cancer	0.000335	0.00534	CcSEcCtD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CCND1—head and neck cancer	0.000313	0.0088	CbGpPWpGaD
Azacitidine—DNMT1—lymph node—head and neck cancer	0.000311	0.026	CbGeAlD
Azacitidine—Pleural effusion—Docetaxel—head and neck cancer	0.00031	0.00494	CcSEcCtD
Azacitidine—Coma—Fluorouracil—head and neck cancer	0.0003	0.00479	CcSEcCtD
Azacitidine—Pancytopenia—Vinblastine—head and neck cancer	0.000298	0.00475	CcSEcCtD
Azacitidine—Rhinorrhoea—Docetaxel—head and neck cancer	0.000293	0.00467	CcSEcCtD
Azacitidine—Rigors—Docetaxel—head and neck cancer	0.00029	0.00463	CcSEcCtD
Azacitidine—Sepsis—Fluorouracil—head and neck cancer	0.000285	0.00454	CcSEcCtD
Azacitidine—Depression—Vinblastine—head and neck cancer	0.000279	0.00445	CcSEcCtD
Azacitidine—Pancytopenia—Hydroxyurea—head and neck cancer	0.000272	0.00433	CcSEcCtD
Azacitidine—Neutropenia—Hydroxyurea—head and neck cancer	0.000268	0.00427	CcSEcCtD
Azacitidine—Dysuria—Hydroxyurea—head and neck cancer	0.000268	0.00427	CcSEcCtD
Azacitidine—Agranulocytosis—Vinblastine—head and neck cancer	0.000261	0.00416	CcSEcCtD
Azacitidine—Infestation—Hydroxyurea—head and neck cancer	0.000255	0.00407	CcSEcCtD
Azacitidine—Infestation NOS—Hydroxyurea—head and neck cancer	0.000255	0.00407	CcSEcCtD
Azacitidine—Haemoglobin—Vinblastine—head and neck cancer	0.000253	0.00403	CcSEcCtD
Azacitidine—Haemorrhage—Vinblastine—head and neck cancer	0.000251	0.00401	CcSEcCtD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	0.000251	0.00705	CbGpPWpGaD
Azacitidine—Hypoaesthesia—Vinblastine—head and neck cancer	0.00025	0.00399	CcSEcCtD
Azacitidine—Pharyngitis—Vinblastine—head and neck cancer	0.000249	0.00398	CcSEcCtD
Azacitidine—Stomatitis—Hydroxyurea—head and neck cancer	0.000249	0.00397	CcSEcCtD
Azacitidine—Bone pain—Docetaxel—head and neck cancer	0.000247	0.00395	CcSEcCtD
Azacitidine—Inflammation—Docetaxel—head and neck cancer	0.000244	0.0039	CcSEcCtD
Azacitidine—Cardiac failure—Fluorouracil—head and neck cancer	0.000244	0.0039	CcSEcCtD
Azacitidine—Lethargy—Fluorouracil—head and neck cancer	0.000243	0.00388	CcSEcCtD
Azacitidine—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000241	0.00385	CcSEcCtD
Azacitidine—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.000238	0.0038	CcSEcCtD
Azacitidine—Injection site reaction—Docetaxel—head and neck cancer	0.000236	0.00376	CcSEcCtD
Azacitidine—Haemoglobin—Hydroxyurea—head and neck cancer	0.00023	0.00367	CcSEcCtD
Azacitidine—Haemorrhage—Hydroxyurea—head and neck cancer	0.000229	0.00365	CcSEcCtD
Azacitidine—Alopecia—Vinblastine—head and neck cancer	0.000222	0.00354	CcSEcCtD
Azacitidine—Dry skin—Fluorouracil—head and neck cancer	0.000219	0.00348	CcSEcCtD
Azacitidine—Neoplasm—Docetaxel—head and neck cancer	0.000214	0.00342	CcSEcCtD
Azacitidine—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000213	0.0034	CcSEcCtD
Azacitidine—Muscular weakness—Fluorouracil—head and neck cancer	0.00021	0.00335	CcSEcCtD
Azacitidine—Angiopathy—Hydroxyurea—head and neck cancer	0.000208	0.00331	CcSEcCtD
Azacitidine—Dysphagia—Fluorouracil—head and neck cancer	0.000206	0.00329	CcSEcCtD
Azacitidine—Sepsis—Docetaxel—head and neck cancer	0.000206	0.00328	CcSEcCtD
Azacitidine—Chills—Hydroxyurea—head and neck cancer	0.000206	0.00328	CcSEcCtD
Azacitidine—Ill-defined disorder—Vinblastine—head and neck cancer	0.000203	0.00324	CcSEcCtD
Azacitidine—Alopecia—Hydroxyurea—head and neck cancer	0.000202	0.00323	CcSEcCtD
Azacitidine—Anaemia—Vinblastine—head and neck cancer	0.000202	0.00322	CcSEcCtD
Azacitidine—Erythema—Hydroxyurea—head and neck cancer	0.000199	0.00318	CcSEcCtD
Azacitidine—Malaise—Vinblastine—head and neck cancer	0.000197	0.00315	CcSEcCtD
Azacitidine—Leukopenia—Vinblastine—head and neck cancer	0.000196	0.00312	CcSEcCtD
Azacitidine—Pancytopenia—Fluorouracil—head and neck cancer	0.000196	0.00312	CcSEcCtD
Azacitidine—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000191	0.00305	CcSEcCtD
Azacitidine—Hepatic failure—Docetaxel—head and neck cancer	0.000191	0.00305	CcSEcCtD
Azacitidine—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00019	0.00303	CcSEcCtD
Azacitidine—Convulsion—Vinblastine—head and neck cancer	0.000189	0.00302	CcSEcCtD
Azacitidine—Hypertension—Vinblastine—head and neck cancer	0.000189	0.00301	CcSEcCtD
Azacitidine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000185	0.00295	CcSEcCtD
Azacitidine—Pneumonia—Fluorouracil—head and neck cancer	0.000185	0.00295	CcSEcCtD
Azacitidine—Anaemia—Hydroxyurea—head and neck cancer	0.000184	0.00294	CcSEcCtD
Azacitidine—Discomfort—Vinblastine—head and neck cancer	0.000184	0.00293	CcSEcCtD
Azacitidine—Infestation NOS—Fluorouracil—head and neck cancer	0.000184	0.00293	CcSEcCtD
Azacitidine—Infestation—Fluorouracil—head and neck cancer	0.000184	0.00293	CcSEcCtD
Azacitidine—Atrial fibrillation—Docetaxel—head and neck cancer	0.000182	0.0029	CcSEcCtD
Azacitidine—Malaise—Hydroxyurea—head and neck cancer	0.00018	0.00287	CcSEcCtD
Azacitidine—Stomatitis—Fluorouracil—head and neck cancer	0.000179	0.00286	CcSEcCtD
Azacitidine—DNMT3A—Chromatin modifying enzymes—CCND1—head and neck cancer	0.000179	0.00503	CbGpPWpGaD
Azacitidine—Urinary tract infection—Fluorouracil—head and neck cancer	0.000179	0.00285	CcSEcCtD
Azacitidine—Leukopenia—Hydroxyurea—head and neck cancer	0.000179	0.00285	CcSEcCtD
Azacitidine—Cardiac failure—Docetaxel—head and neck cancer	0.000176	0.00281	CcSEcCtD
Azacitidine—Lethargy—Docetaxel—head and neck cancer	0.000176	0.0028	CcSEcCtD
Azacitidine—Thrombocytopenia—Vinblastine—head and neck cancer	0.000175	0.00279	CcSEcCtD
Azacitidine—Epistaxis—Fluorouracil—head and neck cancer	0.000173	0.00276	CcSEcCtD
Azacitidine—Convulsion—Hydroxyurea—head and neck cancer	0.000173	0.00276	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—RARB—head and neck cancer	0.000172	0.00484	CbGpPWpGaD
Azacitidine—Sinusitis—Fluorouracil—head and neck cancer	0.000172	0.00275	CcSEcCtD
Azacitidine—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000172	0.00274	CcSEcCtD
Azacitidine—Pain in extremity—Docetaxel—head and neck cancer	0.000172	0.00274	CcSEcCtD
Azacitidine—Agranulocytosis—Fluorouracil—head and neck cancer	0.000171	0.00273	CcSEcCtD
Azacitidine—Anorexia—Vinblastine—head and neck cancer	0.00017	0.00271	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000169	0.00269	CcSEcCtD
Azacitidine—Discomfort—Hydroxyurea—head and neck cancer	0.000168	0.00268	CcSEcCtD
Azacitidine—Haemoglobin—Fluorouracil—head and neck cancer	0.000166	0.00264	CcSEcCtD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	0.000165	0.00465	CbGpPWpGaD
Azacitidine—Rhinitis—Fluorouracil—head and neck cancer	0.000165	0.00264	CcSEcCtD
Azacitidine—Haemorrhage—Fluorouracil—head and neck cancer	0.000165	0.00263	CcSEcCtD
Azacitidine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000164	0.00262	CcSEcCtD
Azacitidine—Pharyngitis—Fluorouracil—head and neck cancer	0.000164	0.00261	CcSEcCtD
Azacitidine—Oedema—Hydroxyurea—head and neck cancer	0.000163	0.0026	CcSEcCtD
Azacitidine—Infection—Hydroxyurea—head and neck cancer	0.000162	0.00258	CcSEcCtD
Azacitidine—Dehydration—Docetaxel—head and neck cancer	0.00016	0.00255	CcSEcCtD
Azacitidine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00016	0.00255	CcSEcCtD
Azacitidine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000159	0.00254	CcSEcCtD
Azacitidine—Skin disorder—Hydroxyurea—head and neck cancer	0.000158	0.00252	CcSEcCtD
Azacitidine—Dry skin—Docetaxel—head and neck cancer	0.000158	0.00251	CcSEcCtD
Azacitidine—Abdominal pain upper—Docetaxel—head and neck cancer	0.000157	0.00251	CcSEcCtD
Azacitidine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000157	0.00251	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—YAP1—head and neck cancer	0.000157	0.0044	CbGpPWpGaD
Azacitidine—Anorexia—Hydroxyurea—head and neck cancer	0.000155	0.00247	CcSEcCtD
Azacitidine—Decreased appetite—Vinblastine—head and neck cancer	0.000155	0.00247	CcSEcCtD
Azacitidine—Cramp muscle—Docetaxel—head and neck cancer	0.000155	0.00247	CcSEcCtD
Azacitidine—Nasopharyngitis—Docetaxel—head and neck cancer	0.000154	0.00245	CcSEcCtD
Azacitidine—Constipation—Vinblastine—head and neck cancer	0.000153	0.00243	CcSEcCtD
Azacitidine—Pain—Vinblastine—head and neck cancer	0.000153	0.00243	CcSEcCtD
Azacitidine—Dysphagia—Docetaxel—head and neck cancer	0.000149	0.00237	CcSEcCtD
Azacitidine—Feeling abnormal—Vinblastine—head and neck cancer	0.000147	0.00235	CcSEcCtD
Azacitidine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000146	0.00233	CcSEcCtD
Azacitidine—Alopecia—Fluorouracil—head and neck cancer	0.000146	0.00232	CcSEcCtD
Azacitidine—Dyspnoea—Hydroxyurea—head and neck cancer	0.000145	0.00231	CcSEcCtD
Azacitidine—Erythema—Fluorouracil—head and neck cancer	0.000144	0.00229	CcSEcCtD
Azacitidine—Dyspepsia—Hydroxyurea—head and neck cancer	0.000143	0.00228	CcSEcCtD
Azacitidine—Decreased appetite—Hydroxyurea—head and neck cancer	0.000142	0.00226	CcSEcCtD
Azacitidine—Pancytopenia—Docetaxel—head and neck cancer	0.000141	0.00225	CcSEcCtD
Azacitidine—Abdominal pain—Vinblastine—head and neck cancer	0.000141	0.00225	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000141	0.00224	CcSEcCtD
Azacitidine—CDA—Metabolism—NAT2—head and neck cancer	0.00014	0.00395	CbGpPWpGaD
Azacitidine—Fatigue—Hydroxyurea—head and neck cancer	0.00014	0.00224	CcSEcCtD
Azacitidine—Constipation—Hydroxyurea—head and neck cancer	0.000139	0.00222	CcSEcCtD
Azacitidine—Pain—Hydroxyurea—head and neck cancer	0.000139	0.00222	CcSEcCtD
Azacitidine—Neutropenia—Docetaxel—head and neck cancer	0.000139	0.00222	CcSEcCtD
Azacitidine—Weight decreased—Docetaxel—head and neck cancer	0.000135	0.00215	CcSEcCtD
Azacitidine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000134	0.00214	CcSEcCtD
Azacitidine—Pneumonia—Docetaxel—head and neck cancer	0.000133	0.00213	CcSEcCtD
Azacitidine—Anaemia—Fluorouracil—head and neck cancer	0.000133	0.00212	CcSEcCtD
Azacitidine—Infestation NOS—Docetaxel—head and neck cancer	0.000133	0.00211	CcSEcCtD
Azacitidine—Infestation—Docetaxel—head and neck cancer	0.000133	0.00211	CcSEcCtD
Azacitidine—Hypersensitivity—Vinblastine—head and neck cancer	0.000132	0.0021	CcSEcCtD
Azacitidine—Renal failure—Docetaxel—head and neck cancer	0.00013	0.00208	CcSEcCtD
Azacitidine—Stomatitis—Docetaxel—head and neck cancer	0.000129	0.00206	CcSEcCtD
Azacitidine—Body temperature increased—Hydroxyurea—head and neck cancer	0.000129	0.00205	CcSEcCtD
Azacitidine—Leukopenia—Fluorouracil—head and neck cancer	0.000129	0.00205	CcSEcCtD
Azacitidine—Asthenia—Vinblastine—head and neck cancer	0.000128	0.00204	CcSEcCtD
Azacitidine—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000125	0.002	CcSEcCtD
Azacitidine—Epistaxis—Docetaxel—head and neck cancer	0.000125	0.00199	CcSEcCtD
Azacitidine—Convulsion—Fluorouracil—head and neck cancer	0.000124	0.00198	CcSEcCtD
Azacitidine—Agranulocytosis—Docetaxel—head and neck cancer	0.000124	0.00197	CcSEcCtD
Azacitidine—CDA—Metabolism—DPYD—head and neck cancer	0.000123	0.00346	CbGpPWpGaD
Azacitidine—Chest pain—Fluorouracil—head and neck cancer	0.000122	0.00195	CcSEcCtD
Azacitidine—Myalgia—Fluorouracil—head and neck cancer	0.000122	0.00195	CcSEcCtD
Azacitidine—Diarrhoea—Vinblastine—head and neck cancer	0.000122	0.00195	CcSEcCtD
Azacitidine—Discomfort—Fluorouracil—head and neck cancer	0.000121	0.00193	CcSEcCtD
Azacitidine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00012	0.00191	CcSEcCtD
Azacitidine—Haemoglobin—Docetaxel—head and neck cancer	0.00012	0.00191	CcSEcCtD
Azacitidine—Rhinitis—Docetaxel—head and neck cancer	0.000119	0.0019	CcSEcCtD
Azacitidine—Haemorrhage—Docetaxel—head and neck cancer	0.000119	0.0019	CcSEcCtD
Azacitidine—Hypoaesthesia—Docetaxel—head and neck cancer	0.000118	0.00189	CcSEcCtD
Azacitidine—Confusional state—Fluorouracil—head and neck cancer	0.000118	0.00188	CcSEcCtD
Azacitidine—Pharyngitis—Docetaxel—head and neck cancer	0.000118	0.00188	CcSEcCtD
Azacitidine—Dizziness—Vinblastine—head and neck cancer	0.000118	0.00188	CcSEcCtD
Azacitidine—Urinary tract disorder—Docetaxel—head and neck cancer	0.000118	0.00187	CcSEcCtD
Azacitidine—Oedema peripheral—Docetaxel—head and neck cancer	0.000117	0.00187	CcSEcCtD
Azacitidine—Oedema—Fluorouracil—head and neck cancer	0.000117	0.00187	CcSEcCtD
Azacitidine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000117	0.00187	CcSEcCtD
Azacitidine—Connective tissue disorder—Docetaxel—head and neck cancer	0.000117	0.00187	CcSEcCtD
Azacitidine—CDA—Metabolism—YAP1—head and neck cancer	0.000117	0.00328	CbGpPWpGaD
Azacitidine—Asthenia—Hydroxyurea—head and neck cancer	0.000117	0.00186	CcSEcCtD
Azacitidine—Urethral disorder—Docetaxel—head and neck cancer	0.000117	0.00186	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—RARB—head and neck cancer	0.000116	0.00327	CbGpPWpGaD
Azacitidine—Infection—Fluorouracil—head and neck cancer	0.000116	0.00186	CcSEcCtD
Azacitidine—Nervous system disorder—Fluorouracil—head and neck cancer	0.000115	0.00183	CcSEcCtD
Azacitidine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000115	0.00183	CcSEcCtD
Azacitidine—Tachycardia—Fluorouracil—head and neck cancer	0.000114	0.00182	CcSEcCtD
Azacitidine—Vomiting—Vinblastine—head and neck cancer	0.000113	0.00181	CcSEcCtD
Azacitidine—Headache—Vinblastine—head and neck cancer	0.000112	0.00178	CcSEcCtD
Azacitidine—Anorexia—Fluorouracil—head and neck cancer	0.000112	0.00178	CcSEcCtD
Azacitidine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000111	0.00178	CcSEcCtD
Azacitidine—Eye disorder—Docetaxel—head and neck cancer	0.000111	0.00177	CcSEcCtD
Azacitidine—Cardiac disorder—Docetaxel—head and neck cancer	0.00011	0.00176	CcSEcCtD
Azacitidine—Hypotension—Fluorouracil—head and neck cancer	0.000109	0.00175	CcSEcCtD
Azacitidine—Angiopathy—Docetaxel—head and neck cancer	0.000108	0.00172	CcSEcCtD
Azacitidine—Dizziness—Hydroxyurea—head and neck cancer	0.000108	0.00172	CcSEcCtD
Azacitidine—Immune system disorder—Docetaxel—head and neck cancer	0.000108	0.00171	CcSEcCtD
Azacitidine—Mediastinal disorder—Docetaxel—head and neck cancer	0.000107	0.00171	CcSEcCtD
Azacitidine—Chills—Docetaxel—head and neck cancer	0.000107	0.0017	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000107	0.0017	CcSEcCtD
Azacitidine—Nausea—Vinblastine—head and neck cancer	0.000106	0.00169	CcSEcCtD
Azacitidine—Insomnia—Fluorouracil—head and neck cancer	0.000106	0.00169	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—YAP1—head and neck cancer	0.000106	0.00297	CbGpPWpGaD
Azacitidine—Alopecia—Docetaxel—head and neck cancer	0.000105	0.00168	CcSEcCtD
Azacitidine—Dyspnoea—Fluorouracil—head and neck cancer	0.000104	0.00167	CcSEcCtD
Azacitidine—Mental disorder—Docetaxel—head and neck cancer	0.000104	0.00166	CcSEcCtD
Azacitidine—Erythema—Docetaxel—head and neck cancer	0.000104	0.00165	CcSEcCtD
Azacitidine—Malnutrition—Docetaxel—head and neck cancer	0.000104	0.00165	CcSEcCtD
Azacitidine—Vomiting—Hydroxyurea—head and neck cancer	0.000103	0.00165	CcSEcCtD
Azacitidine—Dyspepsia—Fluorouracil—head and neck cancer	0.000103	0.00164	CcSEcCtD
Azacitidine—Rash—Hydroxyurea—head and neck cancer	0.000103	0.00164	CcSEcCtD
Azacitidine—Dermatitis—Hydroxyurea—head and neck cancer	0.000103	0.00164	CcSEcCtD
Azacitidine—Headache—Hydroxyurea—head and neck cancer	0.000102	0.00163	CcSEcCtD
Azacitidine—Decreased appetite—Fluorouracil—head and neck cancer	0.000102	0.00162	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000101	0.00161	CcSEcCtD
Azacitidine—Back pain—Docetaxel—head and neck cancer	0.0001	0.0016	CcSEcCtD
Azacitidine—Pain—Fluorouracil—head and neck cancer	0.0001	0.0016	CcSEcCtD
Azacitidine—Muscle spasms—Docetaxel—head and neck cancer	9.96e-05	0.00159	CcSEcCtD
Azacitidine—Nausea—Hydroxyurea—head and neck cancer	9.67e-05	0.00154	CcSEcCtD
Azacitidine—Feeling abnormal—Fluorouracil—head and neck cancer	9.66e-05	0.00154	CcSEcCtD
Azacitidine—Anaemia—Docetaxel—head and neck cancer	9.58e-05	0.00153	CcSEcCtD
Azacitidine—Urticaria—Fluorouracil—head and neck cancer	9.31e-05	0.00148	CcSEcCtD
Azacitidine—Syncope—Docetaxel—head and neck cancer	9.29e-05	0.00148	CcSEcCtD
Azacitidine—Leukopenia—Docetaxel—head and neck cancer	9.28e-05	0.00148	CcSEcCtD
Azacitidine—Body temperature increased—Fluorouracil—head and neck cancer	9.26e-05	0.00148	CcSEcCtD
Azacitidine—Loss of consciousness—Docetaxel—head and neck cancer	9.11e-05	0.00145	CcSEcCtD
Azacitidine—Cough—Docetaxel—head and neck cancer	9.04e-05	0.00144	CcSEcCtD
Azacitidine—Convulsion—Docetaxel—head and neck cancer	8.98e-05	0.00143	CcSEcCtD
Azacitidine—Hypertension—Docetaxel—head and neck cancer	8.95e-05	0.00143	CcSEcCtD
Azacitidine—Arthralgia—Docetaxel—head and neck cancer	8.82e-05	0.00141	CcSEcCtD
Azacitidine—Chest pain—Docetaxel—head and neck cancer	8.82e-05	0.00141	CcSEcCtD
Azacitidine—Myalgia—Docetaxel—head and neck cancer	8.82e-05	0.00141	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	8.76e-05	0.0014	CcSEcCtD
Azacitidine—Hypersensitivity—Fluorouracil—head and neck cancer	8.63e-05	0.00138	CcSEcCtD
Azacitidine—Confusional state—Docetaxel—head and neck cancer	8.53e-05	0.00136	CcSEcCtD
Azacitidine—Oedema—Docetaxel—head and neck cancer	8.46e-05	0.00135	CcSEcCtD
Azacitidine—Anaphylactic shock—Docetaxel—head and neck cancer	8.46e-05	0.00135	CcSEcCtD
Azacitidine—Infection—Docetaxel—head and neck cancer	8.4e-05	0.00134	CcSEcCtD
Azacitidine—Shock—Docetaxel—head and neck cancer	8.32e-05	0.00133	CcSEcCtD
Azacitidine—Nervous system disorder—Docetaxel—head and neck cancer	8.29e-05	0.00132	CcSEcCtD
Azacitidine—Pruritus—Fluorouracil—head and neck cancer	8.29e-05	0.00132	CcSEcCtD
Azacitidine—Thrombocytopenia—Docetaxel—head and neck cancer	8.28e-05	0.00132	CcSEcCtD
Azacitidine—Tachycardia—Docetaxel—head and neck cancer	8.25e-05	0.00132	CcSEcCtD
Azacitidine—Skin disorder—Docetaxel—head and neck cancer	8.21e-05	0.00131	CcSEcCtD
Azacitidine—Anorexia—Docetaxel—head and neck cancer	8.06e-05	0.00129	CcSEcCtD
Azacitidine—Diarrhoea—Fluorouracil—head and neck cancer	8.02e-05	0.00128	CcSEcCtD
Azacitidine—Hypotension—Docetaxel—head and neck cancer	7.9e-05	0.00126	CcSEcCtD
Azacitidine—Dizziness—Fluorouracil—head and neck cancer	7.75e-05	0.00124	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	7.7e-05	0.00123	CcSEcCtD
Azacitidine—Insomnia—Docetaxel—head and neck cancer	7.65e-05	0.00122	CcSEcCtD
Azacitidine—Dyspnoea—Docetaxel—head and neck cancer	7.54e-05	0.0012	CcSEcCtD
Azacitidine—Vomiting—Fluorouracil—head and neck cancer	7.45e-05	0.00119	CcSEcCtD
Azacitidine—Dyspepsia—Docetaxel—head and neck cancer	7.44e-05	0.00119	CcSEcCtD
Azacitidine—Rash—Fluorouracil—head and neck cancer	7.39e-05	0.00118	CcSEcCtD
Azacitidine—Dermatitis—Fluorouracil—head and neck cancer	7.38e-05	0.00118	CcSEcCtD
Azacitidine—Decreased appetite—Docetaxel—head and neck cancer	7.35e-05	0.00117	CcSEcCtD
Azacitidine—Headache—Fluorouracil—head and neck cancer	7.34e-05	0.00117	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Docetaxel—head and neck cancer	7.3e-05	0.00116	CcSEcCtD
Azacitidine—Fatigue—Docetaxel—head and neck cancer	7.29e-05	0.00116	CcSEcCtD
Azacitidine—Pain—Docetaxel—head and neck cancer	7.23e-05	0.00115	CcSEcCtD
Azacitidine—Constipation—Docetaxel—head and neck cancer	7.23e-05	0.00115	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—NOTCH1—head and neck cancer	7.07e-05	0.00198	CbGpPWpGaD
Azacitidine—CDA—Metabolism—TYMS—head and neck cancer	7.02e-05	0.00197	CbGpPWpGaD
Azacitidine—Feeling abnormal—Docetaxel—head and neck cancer	6.97e-05	0.00111	CcSEcCtD
Azacitidine—Nausea—Fluorouracil—head and neck cancer	6.96e-05	0.00111	CcSEcCtD
Azacitidine—CDA—Metabolism—GSTM1—head and neck cancer	6.94e-05	0.00195	CbGpPWpGaD
Azacitidine—Gastrointestinal pain—Docetaxel—head and neck cancer	6.92e-05	0.0011	CcSEcCtD
Azacitidine—Abdominal pain—Docetaxel—head and neck cancer	6.69e-05	0.00107	CcSEcCtD
Azacitidine—Body temperature increased—Docetaxel—head and neck cancer	6.69e-05	0.00107	CcSEcCtD
Azacitidine—CDA—Metabolism—GPX1—head and neck cancer	6.65e-05	0.00187	CbGpPWpGaD
Azacitidine—CDA—Metabolism—CYP1A1—head and neck cancer	6.58e-05	0.00185	CbGpPWpGaD
Azacitidine—Hypersensitivity—Docetaxel—head and neck cancer	6.23e-05	0.000994	CcSEcCtD
Azacitidine—Asthenia—Docetaxel—head and neck cancer	6.07e-05	0.000968	CcSEcCtD
Azacitidine—Pruritus—Docetaxel—head and neck cancer	5.98e-05	0.000954	CcSEcCtD
Azacitidine—Diarrhoea—Docetaxel—head and neck cancer	5.79e-05	0.000923	CcSEcCtD
Azacitidine—Dizziness—Docetaxel—head and neck cancer	5.59e-05	0.000892	CcSEcCtD
Azacitidine—Vomiting—Docetaxel—head and neck cancer	5.38e-05	0.000857	CcSEcCtD
Azacitidine—Rash—Docetaxel—head and neck cancer	5.33e-05	0.00085	CcSEcCtD
Azacitidine—Dermatitis—Docetaxel—head and neck cancer	5.33e-05	0.00085	CcSEcCtD
Azacitidine—Headache—Docetaxel—head and neck cancer	5.3e-05	0.000845	CcSEcCtD
Azacitidine—Nausea—Docetaxel—head and neck cancer	5.02e-05	0.000801	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—NOTCH1—head and neck cancer	4.77e-05	0.00134	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PTGS2—head and neck cancer	3.91e-05	0.0011	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—MAPK3—head and neck cancer	3.91e-05	0.0011	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PTEN—head and neck cancer	3.41e-05	0.000958	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—MAPK3—head and neck cancer	2.64e-05	0.000742	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—AKT1—head and neck cancer	2.64e-05	0.000741	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PIK3CA—head and neck cancer	2.41e-05	0.000676	CbGpPWpGaD
Azacitidine—CDA—Metabolism—AKT1—head and neck cancer	1.97e-05	0.000552	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—AKT1—head and neck cancer	1.78e-05	0.0005	CbGpPWpGaD
